Nouveauté

Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

R. K. ROSS ; E. V. NUNES ; M. OLFSON ; M. SHULMAN ; N. KRAWCZYK ; E. A. STUART ; K. E. RUDOLPH | 2024
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique

BACKGROUND AND AIMS: Extended-release naltrexone (XR-NTX) and sublingual buprenorphine (SL-BUP) are both approved for opioid use disorder (OUD) treatment in any medical setting. We aimed to compare the real-world effectiveness of XR-NTX and SL-B[...]

Plus d'info

Ajouter à la sélection

Lien externe

The impact of cannabis legalization in Uruguay on adolescent cannabis use

H. LAQUEUR ; A. RIVERA-AGUIRRE ; A. SHEV ; A. CASTILLO-CARNIGLIA ; K. E. RUDOLPH ; J. RAMIREZ ; S. S. MARTINS ; M. CERDA | 2020
Dans International Journal of Drug Policy (Vol.80, June 2020) Article : Périodique

ENGLISH: Background: In 2013, Uruguay became the first country in the world to legalize recreational cannabis, instituting a non-commercial state regulatory model of production and supply. This study provides the first empirical evidence on its[...]

Plus d'info

Ajouter à la sélection